Roche Diagnostics, the Diagnostics Division of global healthcare company Roche records a strong start to 2014, recording a seven percent increase in sales overall, according to the global COO during a Dubai visit this week.

Speaking during a market visit of the Roche Diagnostic Leadership team, Roland Diggelmann, Chief Operating Officer of Roche Diagnostics said: “Roche Diagnostics had a strong first quarter. We grew above the market and our leading platform and assay pipeline positions us well for future growth. We’ve launched five key products this quarter, further advancing our offering to our core lab business.”

All regions of Roche Diagnostics grew faster than market, including the EMEA region. With Dubai seeking to become a global healthcare destination, Roche is taking an even more active role in the region with the recent establishment of its legal entity in Egypt.

Diggelmann continued: “We are increasingly focusing on emerging markets, and we see the Middle East as a growth area with huge potential. We feel confident that our cutting edge technologies and high-quality solutions can help the region improve the health of its people as well as making healthcare more efficient.”

Moritz Hartmann, General Manager, Roche Diagnostics Middle East adds: “With our direct presence in the Middle East, we are continuously exploring ways to improve and develop healthcare in the region.  The UAE healthcare system for example is focused on providing high quality and meeting global standards, which Roche Diagnostics Middle East aims to support. Our growing menu of services and our expanding reach, allows us to collaborate with our customers and relevant healthcare bodies to improve accreditation requirements, regional expertise and efficiency - an important factor for emerging markets and the Middle East in particular. All in all, the fundamentals are in place for a strong and continuous growth in the region.”

Roche Diagnostic’s clinical labs business saw the biggest growth, recording a nine percent and four percent increase in sales in Professional and Molecular Diagnostics respectively. Diabetes care sales increased by five percent despite a market environment that continues to be volatile, and tissue diagnostics grew by four percent.

We accept Guest Posts

Download the Dubai City Guide iPhone mobile app

DubaiCityGuide.com is owned and managed by Cyber Gear